A randomised, open label, phase IV comparative study to determine the effects on renal function of continuing treatment with tenofovir versus replacement with abacavir in HIV positive persons
Latest Information Update: 30 Jul 2019
At a glance
- Drugs Abacavir (Primary) ; Tenofovir disoproxil fumarate (Primary)
- Indications HIV infections; HIV-1 infections
- Focus Adverse reactions
- Acronyms Renal switch study
Most Recent Events
- 30 Jul 2019 New trial record